Skip to main content

Advertisement

Log in

Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score

Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The presence of pathologically positive lymph nodes (pN+) is a well-known prognostic factor in oral squamous cell carcinoma (OSCC). The aims of this retrospective multicenter study were to assess the prognosis of OSCC patients with pN+ disease; to compare the prognosis of patients with pN+ disease who underwent surgery plus radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) with that of patients who underwent surgery only; and to account for biases associated with treatment selection of adjuvant RT or CCRT.

Methods

The records of 313 OSCC patients with pN+ disease were retrospectively reviewed. The main outcome measures were 5-year disease-specific survival (DSS) and overall survival (OS) rates. To reduce selection biases associated with retrospective data, the treatment groups were evaluated by Cox proportional hazard analysis with propensity score as a covariate.

Results

The 5-year OS and DSS survival rates for the entire patient cohort were 51.8 and 59.2 %, respectively. T3–4 stage, closed (<5 mm) margin distance, ≥4 involved nodes, and extracapsular spread were significant poor prognostic factors for OS and DSS. In the propensity score analysis, postoperative RT/CCRT significantly improved OS and DSS compared to surgery only. However, OS and DSS were not significantly different between patients who received postoperative RT and CCRT.

Conclusion

The addition of cytotoxic chemotherapy to RT does not provide additional survival benefit in OSCC patients with pN+ disease. Alternative strategies, such as molecular targeted therapies, are needed to further improve the survival of high-risk OSCC patients with pN+ disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics, 2011. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309–16.

    Article  PubMed  Google Scholar 

  3. Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45:201–11.

    Article  PubMed  Google Scholar 

  4. Shingaki S, Takada M, Sasai K, et al. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg. 2003;185:278–84.

    Article  PubMed  Google Scholar 

  5. Ebrahimi A, Zhang WJ, Gao K, Clark JR. Nodal yield and survival in oral squamous cancer. Cancer. 2011;117:2917–25.

    Article  PubMed  Google Scholar 

  6. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350:1945–52.

    Article  PubMed  CAS  Google Scholar 

  7. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350:1937–44.

    Article  PubMed  Google Scholar 

  8. Bernier J, Cooper J, Pajak T, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (22931) and RTOG (9501). Head Neck. 2005;27:843–50.

    Article  PubMed  Google Scholar 

  9. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571–8.

    Article  PubMed  CAS  Google Scholar 

  10. Kao J, Lavaf A, Teng MS, Huang D, Genden EM. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys. 2008;71:362–70.

    Article  PubMed  Google Scholar 

  11. Kiyota N, Tahara M, Okano S, et al. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck. Jpn J Clin Oncol. 2012;42:927–33.

    Article  PubMed  Google Scholar 

  12. Greenberg JS, Fowler R, Gomez J, et al. Extent of extracapsular spread: acritical prognosticator in oral tongue cancer. Cancer. 2003;97:1464–70.

    Article  PubMed  Google Scholar 

  13. Greenberg JS, El Naggar AK, Mo V, Roberts D, Myers JN. Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Cancer. 2003;98:508–15.

    Article  PubMed  Google Scholar 

  14. Fan KH, Lin CY, Kang CJ, et al. Postoperative concomitant chemotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors. PLoS One. 2014;9:e86922.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Takahashi H, Yanamoto S, Yamada S, et al. Effects of postoperative chemotherapy and radiotherapy on patients with squamous cell carcinoma of the oral cavity and multiple regional lymph node metastases. Int J Oral Maxillofac Surg. 2014;43:680–5.

    Article  PubMed  CAS  Google Scholar 

  16. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2003;32:30–4.

    Article  PubMed  CAS  Google Scholar 

  17. Nason RW, Binahmed A, Pathak KA, Abdoh AA, Sándor GK. What is the adequate margin of surgical resection in oral cancer? Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:625–9.

    Article  PubMed  Google Scholar 

  18. Kurita H, Nakanishi Y, Nishizawa R, et al. Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol. 2010;46:814–7.

    Article  PubMed  Google Scholar 

  19. Koloutsos G, Vahtsevanos K, Kyrgidis A, Kechagias N, Triaridis S, Antoniades K. Neck dissection in relation with disease-free, disease-specific, and overall survival of patients with squamous cell cancer of the oral cavity. J Craniofac Surg. 2014;25:1992–7.

    PubMed  Google Scholar 

  20. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Head and neck cancers. Version 2. 2014. www.nccn.org/. Accessed April 28, 2015.

  21. Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG 9501/Intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84:1198–205.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Herman MP, Dagan R, Amdur RJ, et al. Postoperative radiotherapy for patients at high risk of recurrence of oral cavity squamous cell carcinoma. Laryngoscope. 2015;125:630–5.

    Article  PubMed  Google Scholar 

  23. Yanamoto S, Yamada S, Takahashi H, et al. Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2012;41:1195–200.

    Article  PubMed  CAS  Google Scholar 

  24. Grégoire V, Lefebvre JL, Lictra L, Felip E; EHNS-ESMO-ESTRO Guidelines Working Group. squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v184–6.

    Article  PubMed  Google Scholar 

  25. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol. 2003;66:253–62.

    Article  PubMed  Google Scholar 

  26. Winquist E, Oliver T, Gilbert R. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis. Head Neck. 2007;29:38–46.

    Article  PubMed  Google Scholar 

  27. Machtay M, Moughan J, Trotti A, et al. Factors associated with severelate toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008;26:3582–9.

    Article  PubMed  CAS  Google Scholar 

  28. Harari PM, Harris J, Kies MS, et al. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol. 2014;32:2486–95.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgment

We would like to thank Editage (http://www.editage.jp/) for English-language editing.

Disclosure

The authors have no commercial associations or financial disclosures that might pose or create a conflict of interest with the information presented in this article.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Souichi Yanamoto DDS, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yanamoto, S., Otsuru, M., Ota, Y. et al. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score. Ann Surg Oncol 22 (Suppl 3), 992–999 (2015). https://doi.org/10.1245/s10434-015-4824-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4824-5

Keywords

Navigation